MARIPOSA: Combination therapy as the new standard of care for EGFR-mutated NSCLC - Medizinonline

… Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitreten Already a member? Log in here...

Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich
Jetzt beitreten

Already a member? Log in here

Autoren

Birke Dikken

Publikation

InFo ONKOLOGIE & HÄMATOLOGIE

Related Topics

Previous Article

Atopic dermatitis and allergies Atopic dermatitis and allergies

Type 2 inflammation and other factors

Diabetes mellitus

Treatment of comorbidities in older people

You May Also Like

3 min

Asthma in Adults: Bronchodilation and Anti-Inflammatory Therapy

Remodeling can be counteracted through a proactive treatment strategy

3 min

From symptom to diagnosis

Gynecomastia and Adipomastia

7 min

Plastic surgery and reconstructive microsurgery for DFS

Functional limb preservation between infection control, vascular medicine and resurfacing

12 min

SURPASS-CVOT

Tirzepatide versus Dulaglutide in T2D with ASCVD

6 min

Secondary prevention after ACS: individually optimized lipid management

Trend towards early combination therapy and new strategies for lowering Lp(a)

27 min

Pediatric Brain Tumors

Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls

13 min

What the latest studies on the entire EF spectrum mean for clinical practice

Heart Failure – The 2026 Evidence Update

5 min

Acute ischemic stroke

Alteplase and Tenecteplase Are on the Same Level

Input your search keywords and press Enter.